Publication | Open Access

Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors

Tumor ImmunologyCancer ImmunosurveillancePd-1 BlockadeImmunologyImmunoeditingImmune Checkpoint InhibitorDistinct RolesImmunomodulationImmunotherapyMedicineCell BiologyTumor MicroenvironmentTlr3/9 Agonists